IL13RA2 gene polymorphisms are associated with systemic sclerosis

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 2015-2019

  Granel, Brigitte ^a,b   Allanore, Yannick ^f   Chevillard, Christophe ^c   Arnaud, Violaine ^c   Marquet, Sandrine ^c   Weiller, Pierre Jean ^g   Durand, Jean Marc ^h   Harlé, Jean Robert ^h   Grange, Claire ⁱ   Frances, Yves ^d,e   Berbis, Philippe ^e   Gaudart, Jean ^j   De Micco, Philippe ^k   Kahan, André ^f   Dessein, Alain ^c  

^a INSERM   (France)

^b HÔPITAL NORD   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Hopital Nord   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g TIMONE HOSPITAL   (France)

^h HÔPITAL DE LA CONCEPTION   (France)

ⁱ CENTRE HOSPITALIER LYON SUD   (France)

^j AIX MARSEILLE UNIV   (France)

^k ETABLISSEMENT FRANÇAIS DU SANG   (France)

more..

Author keywords

Gene; Genetic susceptibility; Interleukin 13; Interleukin 13 receptor; Single nucleotide polymorphism; Systemic sclerosis

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CUTANEOUS SYSTEMIC SCLEROSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DIFFUSE SYSTEMIC SCLEROSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE; GENE EXPRESSION; GENE LOCATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL13RA1 GENE; IL13RA2 GENE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; X CHROMOSOME;

ADULT; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC; VARIATION (GENETICS);

EID: 33749995177     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Johnson RW, Tew MB, Arnett FC. The genetics of systemic sclerosis. Curr Rheumatol Rep 2002;4:99-107.
2. Assassi S, Tan FK. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays. Curr Opin Rheumatol 2005;17:761-7.
3. Kissin EY, Korn JH. Fibrosis in scleroderma. Rheum Dis Clin North Am 2003;29:351-69.
4. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (1L-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumutol 1997;24:328-32.
5. Riccieri V, Rinaldi T, Spadaro A, et al. Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities. Clin Rheumatol 2003;22:102-6.
6. Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 2003;111:677-90: quiz 691.
7. Kawakami K, Taguchi J, Murata T, Puri RK. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 2001;97:2673-9.
8. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnosis and therapeutic criteria committee. Arthritis Rheum 1980;23:581-90.
9. LeRoy EC, Medsger TA, Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
10. Kouriba B, Chevillard C, Bream JH, et al. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591 A/G polymorphisms and Schistosoma haematobium infections. J Immunol 2005;174:6274-81.
11. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-9.
12. Elias JA, Zheng T, Lee CG, et al. Transgenic modeling of interleukin-13 in the lung. Chest 2003;123(3 Suppl):339S-45S.
13. Matsushita M, Yamamoto T, Nishioka K. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. hit Arch Allergy Immunol 2004;135:348-56.
14. Wood N, Whitters MJ, Jacobson BA, et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med 2003;197:703-9.
15. Chiaramonte MG, Mentink-Kane M, Jacobson BA, et al. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 2003;197:687-701.